AVIVA PLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 49 quarters, returned +0.9% per quarter — versus +2.1% per quarter from simply owning every 13F stock. It beat that baseline in only 40.8% of quarters (excess t = -0.27, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry after the actual SEC deadline plus a 2-day buffer
Top 20 holdings of 854 · 2026 Q2
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| NVDA | $4.4B | | TRIM −4% |
| AAPL | $3.8B | | HOLD |
| MSFT | $2.7B | | HOLD |
| AMZN | $2.1B | | ADD +3% |
| GOOGL | $2.1B | | HOLD |
| AZN | $2.0B | | HOLD |
| AVGO | $1.8B | | HOLD |
| GOOG | $1.6B | | TRIM −4% |
| MU | $1.2B | | ADD +3% |
| META | $1.1B | | ADD +2% |
| TSLA | $1.1B | | HOLD |
| JPM | $1.0B | | HOLD |
| AMD | $916M | | ADD +13% |
| LLY | $862M | | HOLD |
| V | $747M | | HOLD |
| AMAT | $615M | | ADD +19% |
| BRK/B | $596M | | ADD +5% |
| JNJ | $549M | | HOLD |
| INTC | $537M | | HOLD |
| XONA.DE | $510M | | HOLD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q2
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry is the first trading session after the actual SEC filing deadline plus a 2-day buffer. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.